Special Coverage: The Buck Institute for research on aging
Stem-cell advance holds promise in treating blindness
Novato researchers used stem cells to generate photoreceptors then transplanted them into blind rodents.
The Buck’s new CEO tackles aging
Eric Verdin suggests aligning Novato’s The Buck Institute for Research on Aging with organizations that could transform local advances on chronic maladies of aging into human treatments.
Novato biotech goes public via reverse merger
A Novato biotech startup found its way to public stock trading by hooking up with a cigar company.
Novato startup fights Parkinson’s with stem cells
A company founder at the Buck Institute for Research on Aging in Novato has developed stem-cell lines expected to accelerate Parkinson’s disease research.
Novato biotech startup tackles arthritis, glaucoma
Unity Biotechnology First Company in February 2016 propelled into the public arena from its home at The Buck Institute for Research on Aging in Novato.